At a glance
ClinicalIndex Comparison RecordPhase 3Completed· 80 enrolled
Drug / intervention
Glycin max(L.) Merr. peel extract +1 moredietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Effect of Intake of Glycin Max (L.) Merr. Peel Extract on Body Fat and Body Weight
In Brief
A Phase 3 clinical trial evaluating Glycin max(L.) Merr. peel extract and Placebo for Obesity. Completed, enrolled 80 participants across 1 site.
Detailed Summary
The investigators performed a 8-week, randomized, double-blind, placebo-controlled human trial to evaluate the efficacy and safety of Glycin max (L.) Merr. peel extract on decrement of body fat. The investigators measured decrement of body fat parameters , including Body Fat Mass, Percent Body Fat, weight and BMI(body mass index), and monitored their blood pressure.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsObesity
CountriesSouth Korea
Collaborators--
Timeline
Phase 3CompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedApr 2014
Enrollment StartMay 2014
Primary CompletionJul 2014
TodayJul 2026
First PostedApr 9, 2014
Enrollment StartMay 1, 2014
Primary CompletionJul 1, 2014
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 12.2 years ago
Interventions
Glycin max(L.) Merr. peel extractdietary
Glycin max(L.) Merr. peel extract (2.5g/day)
Placebodietary
Placebo (2.5g/day)